Canopy Growth Quietly Launched Its Hemp-Derived CBD Brand in the US

Canopy Growth Corp. (NYSE: CGC, TSX: WEED) has quietly launched its hemp-derived CBD brand in the US consumer market.

According to the report, Canopy’s new U.S. CBD product brand is dubbed “First & Free” and will be available for sale in 31 U.S. states where CBD products are legally available. (BNN)

Canopy reported earlier this year, the company is planning to open hemp processing facilities in seven U.S. states within the next year.

“We have built our hemp supply chain in the United States through partnering with a diverse group of contract farmers and manufacturers across several states for the cultivation, extraction, processing, and production of hemp-derived products,”

the company said in financial documents released last month. 

Canopy’s CBD Brand Website: https://www.firstandfree.com/en

About Canopy Growth Corporation
Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has operations in over a dozen countries across five continents.

Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.

Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.

From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 10.5 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Next Post

Blueberries Medical Harvests First Commercial Crop & Progresses Towards Expected Sales in Early 2020

As the industry and regulations continue to evolve rapidly, we are confident in our ability to meet our key milestones… TORONTO, Dec. 03, 2019 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a Latin American licensed producer of medicinal cannabis and cannabis-derived […]
%d bloggers like this: